Skip Ribbon Commands
Skip to main content

Dr Lim Fangyi

Dr Lim Fang Yi

Dr Lim Fangyi

​MBBS, MRCP (UK), MMed (Singapore)

Associate Consultant

Clinical Appointments

  • Associate Consultant Department of Cardiology National Heart Centre SingaporeNational Heart Centre Singapore

Academic Appointments

  • Physician Faculty Member, SingHealth Cardiology Residency Programme SingHealth Duke-NUS Cardiovascular Sciences Academic Clinical Programme

Profile

​Dr Lim Fang Yi is an Associate Consultant with the Department of Cardiology at the National Heart Centre Singapore. Her clinical subspecialty interests are in heart failure and intensive care medicine.

Education

  • Membership of the Royal Colleges of Physicians of the United Kingdom, MRCP (UK), 2019
  • Master of Medicine (MMed), National University of Singapore, 2019
  • Bachelor of Medicine and Bachelor of Surgery (MBBS), National University of Singapore, 2016

Professional Appointments and Committee Memberships

  • Associate Consultant, Department of Cardiology, National Heart Centre Singapore, February 2024 - Present
  • Senior Resident Committee Chair, SingHealth, July 2021 - June 2022
  • Singapore Chief Residency Programme, July 2020 - June 2021
  • Chief Resident (Overall), Internal Medicine Junior Residency, SingHealth, July 2019 - June 2020
  • Casa Leader (Inaugural), Internal Medicine Junior Residency, SingHealth, July 2018 - June 2019
  • Associate in Education, SingHealth Academy, 2020 - Present
  • Tutor, Yong Loo Lin School of Medicine, National University of Singapore, 2020 - Present
  • Tutor, Duke-NUS School of Medicine, National University of Singapore, 2020 - Present 
  • Tutor, Lee Kong Chian School of Medicine, Nanyang Technological University, 2020-Present

Awards

  • ​Singapore Cardiac Society Jeopardy 1st, 2022 
  • Brunei Cardiac Society MedElevate 2nd, 2022
  • WOW! Award, Changi General Hospital, 2020
  • Outstanding Resident Award, Internal Medicine Junior Residency, SingHealth 2019

Research Interests

Publications and Research Trials

  • ​Safety and Efficacy of Percutaneous Pulmonary Valve Implantation: the Singapore Experience. Lim FY, Foo JS, Yap J, Lee PT Sundarraraghavan S, Tan JL. Journal of Asian Pacific Society of Cardiology.
  • Technical Considerations for Percutaneous Tricuspid Paravalvular Leak Closure. Lim FY, Lee PT, Ewe SH, Tan JWC, Lim ST, Yap J. Journal of Asian Pacific Society of Cardiology. 2023;2(36).
  • Effect of Myocardial Viability Assessed by Cardiac Magnetic Resonance on Survival in Patients with Ischemic Left Ventricular Dysfunction. Yap J, Lim FY, Gao F, Wang SZ, Low SCS, Le TT, Tan RS. Circulation Reports. 2020;2(6):306-313.
  • The Singapore Heart Failure Risk Score: Prediction of Survival in Southeast Asian Patients. Yap J, Chia SY, Lim FY, et al. Ann Acad Med Singapore. 2019;48(3):86‐94.
  • Prediction of Survival in Asian Patients Hospitalized With Heart Failure: Validation of the OPTIMIZE-HF Risk Score. Yap J, Lim FY, Chia SY, et al. J Card Fail. 2019;25(7):571‐575. doi:10.1016/j.cardfail.2019.02.016
  • Correlation of the New York Heart Association classification and the Cardiopulmonary Exercise Test: A systematic review. Lim FY, Yap J, Gao F, Teo LL, Lam CSP, Yeo KK. Int J Cardiol. 2018;263:88‐93.
  • Correlation of the New York Heart Association Classification and the 6-Minute Walk Test: A Systematic Review. Yap J, Lim FY, Gao F, Teo LL, Lam CS, Yeo KK. Clin Cardiol. 2015;38(10):621‐628.

Research Trials

  • Updated on